Tanya: Tell us about your background and what led you to animal health innovation. Jamie: My career has focused on advancing precision molecular technologies, particularly in genomics and targeted protein analysis. I’ve spent more than two decades working at the intersection of science, tr...
Quick Takeaways: Why It Matters? MiDOG’s expanded WGS panel positions it as a high-end reference option for difficult, polymicrobial, or refractory cases, where traditional culture and targeted PCR often fall short. By consolidating bacteria, fungi...
Quick Takeaways: Why It Matters? Automation on the IDS i10 platform lets Volition scale Nu.Q Vet testing volume and speed, making routine cancer screening more practical for large hospital networks. Deeper integration with Fujifilm Vet Systems in Japan also stren...
Quick Takeaways Why It Matters? The partnership allows GekkoVet to scale rapidly in a new geography by leveraging Royal Canin’s established veterinary relationships, positioning its AI platform as an embedded part of day-to-day clinical practice. For R...
Quick Takeaways: Why It Matters? By expanding Cancer Dx and inVue Dx, IDEXX tightens its grip on veterinary oncology workflows, nudging clinics toward proactive, panel-based cancer screening rather than reactive testing. Bundling mast cell detection at no extra c...
Quick Takeaways: Why It Matters? The DR50 Plus strengthens IDEXX’s imaging ecosystem, giving clinics a premium option that combines lower dose with sharper, AI-optimized images. Dose reduction and fewer retakes can improve staff and patient safety, while tighter ...
Quick Takeaways: Why It Matters? The Bioguard agreement deepens KVP SafePath’s diagnostics pipeline with access to a broad reagent/IP library and a faster path to USDA‑licensed 4DX/3DX panels, positioning the company to enter a >$500 million North America...
Rank Companies Animal Health Revenue (2023 $M) Animal Health Revenue (2024 $M) Percent change (%) 1 Zoetis 8,544 9,256 8.33 2 MSD Animal Health 5,625 5,877 4.48 3 BI Animal Health 5,213.60...
20. ImmuCell Revenue: $17.47M Founded Year: 1987 Market Cap: Total Employees: ~100 Headquarters: Portland, United States Stock Exchange: NASDAQ 19. Hester Biosciences Revenue: $33.24M Founded Year: 1987 Market Cap: Total Employees: ~600 Headquarters: Gujrat, India Stock Exchange: NSE 18. V...
20. ImmuCell Revenue: $18.6M Founded Year: 1982 Market Cap: $35.11M Total Employees: ~70 Headquarters: Maine, United States Stock Exchange: NASDAQ 19. Hester Pharmaceuticals & Biotech Revenue: $32M Founded Year: 1987 Market Cap: $150.13 Tota...
